Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Statement by the Board of Directors of Swedish Orphan Biovitrum AB in relation to the public cash offer by Advent and GIC
The Board of Directors of Swedish Orphan Biovitrum AB unanimously recommends that the shareholders of Swedish Orphan Biovitrum AB accept the offer.
Amazon pushes deworming drug falsely touted as Covid treatment
Amazon is directing users to an anti-parasitic drug falsely claimed to be a treatment for Covid-19.
FDA In Brief: FDA Reaches Milestone in Competitive Generic Therapy Drug Approvals
The following quote is attributed to Sally Choe, Ph.
Takeda’s pevonedistat fails to meet primary goal in Phase III leukaemia trial
Takeda Pharmaceutical has reported that its investigational drug, pevonedistat, in combination with azacitidine failed to meet the primary goal of the Phase III PANTHER (Pevonedistat-3001) cli...
SK Bioscience, GSK Launch Phase 3 Trial for COVID-19 Vaccine
GlaxoSmithKline (GSK) and SK Bioscience have begun a phase 3 study of SK’s COVID-19 vaccine candidate, GBP510, in combination with GSK’s adjuvant.
Early use of Uptravi reduces risk of disease progression in PAH patients
New data from a post-hoc pooled analysis of the Phase III GRIPHON and Phase IIIb TRITON trials suggests that early use of Janssen's Uptravi (selexipag) soon after diagnosis may reduce the ...
Xywav set to become Jazz’s next blockbuster in the narcolepsy market, says GlobalData
The Food and Drug Administration (FDA) recently approved a new indication for Jazz Pharmaceuticals’ Xywav for the treatment of patients with idiopathic hypersomnia (IH), a rare neuro...
In a major blow to vaccine efforts, senior FDA leaders stepping down
Two of the FDA’s most senior vaccine leaders are exiting from their positions, raising fresh questions about the Biden administration and the way that it’s sidelined the FDA.
FDA Approves Pembrolizumab for First-Line Treatment of Advanced Bladder Cancer
Pembrolizumab has been granted full approval as a first-line treatment for a select population of patients with bladder cancer.
FDA Approves Tibsovo for Adjuvant Treatment of IDH1-Mutated UC
The FDA approved ivosidenib (Tibsovo, Servier) for adults with previously treated, locally advanced or metastatic cholangiocarcinoma with an isocitrate dehydrogenase-1 (IDH1) mutation ...
UCB Announces Briviact (brivaracetam) Now FDA-Approved to Treat Partial-Onset Seizures in Pediatric Patients One Month of Age and Older
ATLANTA, Aug.
A drug costing less than €2 a day helps in the treatment of severely ill COVID-19 patients
Metoprolol, a drug widely used to treat cardiovascular disease, is beneficial when administered to COVID-19patients.
202
203
204
205
206
207
208
209
210
